ReGenTree, LLC
7 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2 (NCT05555589) | ReGenTree, LLC | 2023-04-11 |
| Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-3 (NCT03937882) | ReGenTree, LLC | 2019-05-24 |
Track ReGenTree, LLC automatically
Every clearance here is in the API, with alerts when new ones post.